miR-622 is a novel potential biomarker of breast carcinoma and impairs motility of breast cancer cells through targeting NUAK1 kinase

BACKGROUND: Aberrant expression of microRNAs (miR) has been proposed as non-invasive biomarkers for breast cancers. The aim of this study was to analyse the miR-622 level in the plasma and in tissues of breast cancer patients and to explore the role of miR-622 and its target, the NUAK1 kinase, in th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Cancer
Main Authors: Orlandella, Francesca Maria, Mariniello, Raffaela Mariarosaria, Mirabelli, Peppino, De Stefano, Anna Elisa, Iervolino, Paola Lucia Chiara, Lasorsa, Vito Alessandro, Capasso, Mario, Giannatiempo, Rosa, Rongo, Maria, Incoronato, Mariarosaria, Messina, Francesco, Salvatore, Marco, Soricelli, Andrea, Salvatore, Giuliana
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7403386/
https://ncbi.nlm.nih.gov/pubmed/32418991
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-020-0884-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados